{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:34:05Z","timestamp":1793064845843,"version":"4.5.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"President Foundation of Zhujiang Hospital, Southern Medical University","id":[{"id":"https:\/\/ror.org\/01vjw4z39","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Post-Marketing Clinical Research Special Project for Innovative Drugs"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Gene Ther"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1038\/s41417-026-01075-y","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T14:23:05Z","timestamp":1787322185000},"page":"1189-1200","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["NAT10 promotes prostate cancer progression by acetylating mRNA of MARK2 and activating mTOR\/HIF-1\u03b1\/C-Myc pathway to enhance glycolytic reprogramming"],"prefix":"10.1038","volume":"33","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-9167","authenticated-orcid":false,"given":"Yiming","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3308-686X","authenticated-orcid":false,"given":"Ganping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingkun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binshen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"1075_CR1","first-page":"485","volume":"75","author":"TB Kratzer","year":"2025","unstructured":"Kratzer TB, Mazzitelli N, Star J, Dahut WL, Jemal A, Siegel RL. Prostate cancer statistics, 2025. CA Cancer J Clin. 2025;75:485\u201397.","journal-title":"CA Cancer J Clin"},{"key":"1075_CR2","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3390\/biom15050625","volume":"15","author":"WA Kwon","year":"2025","unstructured":"Kwon WA, Joung JY. Precision targeting in metastatic prostate cancer: molecular insights to therapeutic frontiers. Biomolecules. 2025;15:625.","journal-title":"Biomolecules"},{"key":"1075_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2023.100962","volume":"68","author":"M Cai","year":"2023","unstructured":"Cai M, Song XL, Li XA, Chen M, Guo J, Yang DH, et al. Current therapy and drug resistance in metastatic castration-resistant prostate cancer. Drug Resist Updat. 2023;68:100962.","journal-title":"Drug Resist Updat"},{"key":"1075_CR4","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/nrg3863","volume":"16","author":"D Holoch","year":"2015","unstructured":"Holoch D, Moazed D. RNA-mediated epigenetic regulation of gene expression. Nat Rev Genet. 2015;16:71\u201384.","journal-title":"Nat Rev Genet"},{"key":"1075_CR5","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.omtn.2020.01.037","volume":"20","author":"G Jin","year":"2020","unstructured":"Jin G, Xu M, Zou M, Duan S. The processing, gene regulation, biological functions, and clinical relevance of N4-acetylcytidine on RNA: a systematic review. Mol Ther Nucleic Acids. 2020;20:13\u201324.","journal-title":"Mol Ther Nucleic Acids"},{"key":"1075_CR6","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2024.1380746","volume":"15","author":"Z Zhang","year":"2024","unstructured":"Zhang Z, Liu J, Wu Y, Gu Z, Zou L, Liu Y, et al. The functions and mechanisms of RNA modification in prostate: current status and future perspectives. Front Genet. 2024;15:1380746.","journal-title":"Front Genet"},{"key":"1075_CR7","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202310131","volume":"11","author":"KJ Li","year":"2024","unstructured":"Li KJ, Hong Y, Yu YZ, Xie Z, Lv DJ, Wang C, et al. NAT10 promotes prostate cancer growth and metastasis by acetylating mRNAs of HMGA1 and KRT8. Adv Sci (Weinh). 2024;11:e2310131.","journal-title":"Adv Sci (Weinh)"},{"key":"1075_CR8","doi-asserted-by":"publisher","first-page":"8534","DOI":"10.1073\/pnas.0509955103","volume":"103","author":"YM Chen","year":"2006","unstructured":"Chen YM, Wang QJ, Hu HS, Yu PC, Zhu J, Drewes G, et al. Microtubule affinity-regulating kinase 2 functions downstream of the PAR-3\/PAR-6\/atypical PKC complex in regulating hippocampal neuronal polarity. Proc Natl Acad Sci USA. 2006;103:8534\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1075_CR9","doi-asserted-by":"publisher","first-page":"3149","DOI":"10.1074\/jbc.M114.629873","volume":"290","author":"SS Deng","year":"2015","unstructured":"Deng SS, Wu LY, Wang YC, Cao PR, Xu L, Li QR, et al. Protein kinase A rescues microtubule affinity-regulating kinase 2-induced microtubule instability and neurite disruption by phosphorylating serine 409. J Biol Chem. 2015;290:3149\u201360.","journal-title":"J Biol Chem"},{"key":"1075_CR10","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1073\/pnas.0701179104","volume":"104","author":"JB Hurov","year":"2007","unstructured":"Hurov JB, Huang M, White LS, Lennerz J, Choi CS, Cho YR, et al. Loss of the Par-1b\/MARK2 polarity kinase leads to increased metabolic rate, decreased adiposity, and insulin hypersensitivity in vivo. Proc Natl Acad Sci USA. 2007;104:5680\u20135.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1075_CR11","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/S0092-8674(00)80208-1","volume":"89","author":"G Drewes","year":"1997","unstructured":"Drewes G, Ebneth A, Preuss U, Mandelkow EM, Mandelkow E. MARK, a novel family of protein kinases that phosphorylate microtubule-associated proteins and trigger microtubule disruption. Cell. 1997;89:297\u2013308.","journal-title":"Cell"},{"key":"1075_CR12","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1042\/EBC20190016","volume":"63","author":"C Garcin","year":"2019","unstructured":"Garcin C, Straube A. Microtubules in cell migration. Essays Biochem. 2019;63:509\u201320.","journal-title":"Essays Biochem"},{"key":"1075_CR13","doi-asserted-by":"crossref","unstructured":"Barlan K, Gelfand VI. Microtubule-Based Transport and the Distribution, Tethering, and Organization of Organelles. Cold Spring Harb Perspect Biol. 2017 May 1;9:a025817.","DOI":"10.1101\/cshperspect.a025817"},{"key":"1075_CR14","first-page":"315","volume":"127","author":"KT Lewandowski","year":"2014","unstructured":"Lewandowski KT, Piwnica-Worms H. Phosphorylation of the E3 ubiquitin ligase RNF41 by the kinase Par-1b is required for epithelial cell polarity. J Cell Sci. 2014;127:315\u201327.","journal-title":"J Cell Sci"},{"key":"1075_CR15","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1146\/annurev.neuro.31.060407.125536","volume":"32","author":"AP Barnes","year":"2009","unstructured":"Barnes AP, Polleux F. Establishment of axon-dendrite polarity in developing neurons. Annu Rev Neurosci. 2009;32:347\u201381.","journal-title":"Annu Rev Neurosci"},{"key":"1075_CR16","doi-asserted-by":"publisher","first-page":"5507","DOI":"10.1111\/bph.12704","volume":"171","author":"CM Fife","year":"2014","unstructured":"Fife CM, McCarroll JA, Kavallaris M. Movers and shakers: cell cytoskeleton in cancer metastasis. Br J Pharm. 2014;171:5507\u201323.","journal-title":"Br J Pharm"},{"key":"1075_CR17","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1016\/j.cub.2022.04.088","volume":"32","author":"AM Pasapera","year":"2022","unstructured":"Pasapera AM, Heissler SM, Eto M, Nishimura Y, Fischer RS, Thiam HR, et al. MARK2 regulates directed cell migration through modulation of myosin II contractility and focal adhesion organization. Curr Biol. 2022;32:2704\u201318.e6.","journal-title":"Curr Biol"},{"key":"1075_CR18","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/jcb.30219","volume":"123","author":"L Ponnusamy","year":"2022","unstructured":"Ponnusamy L, Natarajan SR, Manoharan R. MARK2 potentiate aerobic glycolysis-mediated cell growth in breast cancer through regulating mTOR\/HIF-1alpha and p53 pathways. J Cell Biochem. 2022;123:759\u201371.","journal-title":"J Cell Biochem"},{"key":"1075_CR19","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/s41571-023-00774-x","volume":"20","author":"X Deng","year":"2023","unstructured":"Deng X, Qing Y, Horne D, Huang H, Chen J. The roles and implications of RNA m(6)A modification in cancer. Nat Rev Clin Oncol. 2023;20:507\u201326.","journal-title":"Nat Rev Clin Oncol"},{"key":"1075_CR20","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-024-05687-6","volume":"22","author":"H Ding","year":"2024","unstructured":"Ding H, Liu N, Wang Y, Adam SA, Jin J, Feng W, et al. Implications of RNA pseudouridylation for cancer biology and therapeutics: a narrative review. J Transl Med. 2024;22:906.","journal-title":"J Transl Med"},{"key":"1075_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01417-5","volume":"22","author":"S Zhang","year":"2024","unstructured":"Zhang S, Liu Y, Ma X, Gao X, Ru Y, Hu X, et al. Recent advances in the potential role of RNA N4-acetylcytidine in cancer progression. Cell Commun Signal. 2024;22:49.","journal-title":"Cell Commun Signal"},{"key":"1075_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.738","volume":"12","author":"G Wang","year":"2022","unstructured":"Wang G, Zhang M, Zhang Y, Xie Y, Zou J, Zhong J, et al. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression. Clin Transl Med. 2022;12:e738.","journal-title":"Clin Transl Med"},{"key":"1075_CR23","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1111\/1759-7714.15262","volume":"15","author":"CC Zhao","year":"2024","unstructured":"Zhao CC, Sun X, Chen J, Geng BD. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression. Thorac Cancer. 2024;15:820\u20139.","journal-title":"Thorac Cancer"},{"key":"1075_CR24","doi-asserted-by":"publisher","first-page":"3638","DOI":"10.1093\/nar\/gkaa130","volume":"48","author":"HY Liu","year":"2020","unstructured":"Liu HY, Liu YY, Yang F, Zhang L, Zhang FL, Hu X, et al. Acetylation of MORC2 by NAT10 regulates cell-cycle checkpoint control and resistance to DNA-damaging chemotherapy and radiotherapy in breast cancer. Nucleic Acids Res. 2020;48:3638\u201356.","journal-title":"Nucleic Acids Res"},{"key":"1075_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202302705","volume":"10","author":"X Chen","year":"2023","unstructured":"Chen X, Hao Y, Liu Y, Zhong S, You Y, Ao K, et al. NAT10\/ac4C\/FOXP1 promotes malignant progression and facilitates immunosuppression by reprogramming glycolytic metabolism in cervical cancer. Adv Sci (Weinh). 2023;10:e2302705.","journal-title":"Adv Sci (Weinh)"},{"key":"1075_CR26","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1186\/s13046-022-02551-7","volume":"41","author":"C Jin","year":"2022","unstructured":"Jin C, Wang T, Zhang D, Yang P, Zhang C, Peng W, et al. Acetyltransferase NAT10 regulates the Wnt\/beta-catenin signaling pathway to promote colorectal cancer progression via ac(4)C acetylation of KIF23 mRNA. J Exp Clin Cancer Res. 2022;41:345.","journal-title":"J Exp Clin Cancer Res"},{"key":"1075_CR27","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41417-024-00737-z","volume":"31","author":"Y Lei","year":"2024","unstructured":"Lei Y, Zhang R, Cai F. Role of MARK2 in the nervous system and cancer. Cancer Gene Ther. 2024;31:497\u2013506.","journal-title":"Cancer Gene Ther"},{"key":"1075_CR28","first-page":"1","volume":"11","author":"LM Phan","year":"2014","unstructured":"Phan LM, Yeung SC, Lee MH. Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med. 2014;11:1\u201319.","journal-title":"Cancer Biol Med"},{"key":"1075_CR29","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1007\/978-3-030-32656-2_10","volume":"1210","author":"C Lin","year":"2019","unstructured":"Lin C, Salzillo TC, Bader DA, Wilkenfeld SR, Awad D, Pulliam TL, et al. Prostate cancer energetics and biosynthesis. Adv Exp Med Biol. 2019;1210:185\u2013237.","journal-title":"Adv Exp Med Biol"}],"container-title":["Cancer Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01075-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01075-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T01:05:23Z","timestamp":1793063123000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41417-026-01075-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["1075"],"URL":"https:\/\/doi.org\/10.1038\/s41417-026-01075-y","relation":{},"ISSN":["0929-1903","1476-5500"],"issn-type":[{"value":"0929-1903","type":"print"},{"value":"1476-5500","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"6 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 August 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"Informed consent for biospecimen donation and future research was obtained from all participants before surgery. This study was conducted in accordance with the Declaration of Helsinki and was approved by the Ethics Committee of Zhujiang Hospital, Southern Medical University.","order":2,"name":"Ethics","label":"Ethical approval","group":{"name":"EthicsHeading","label":"Ethics"}}]}}